# FDA recall Z-1812-2018

> **Tosoh Bioscience Inc** · Class II · device recall initiated 2018-03-05.

## Product

Tosoh ST AIA-PACK HbA1c Pretreatment Solution, HbA1c Pretreatment Solution, PN 025718    The device is intended for In Vitro Diagnostic Use Only for the pretreatment of the patient samples or control set for the HbA1c assay

## Reason for recall

The assay can potentially generate erroneously elevated or erroneously decreased HbA1c patient results.

## Distribution

USA (nationwide) Distribution including PR and to the states of :  AL, AR, AZ, CA, CO, CT, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, MI, MO, NC, NE, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.

## Key facts

- **Recall number:** Z-1812-2018
- **Recalling firm:** Tosoh Bioscience Inc
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2018-03-05
- **Report date:** 2018-05-23
- **Termination date:** 2020-06-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Grove City, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1812-2018

## Citation

> AI Analytics. FDA recall Z-1812-2018. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/Z-1812-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*